Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Can asthma protect men from lethal prostate cancer?

Written by | 9 Oct 2015

Men with asthma are less likely to have aggressive prostate cancer or to die from the disease, according to a large, prospective cohort study published in the International… read more.

USA pain by the numbers

Written by | 6 Oct 2015

In one of the largest population studies on pain to date, researchers with the National Institutes of Health estimate that nearly 40 million Americans experience severe pain and… read more.

Effective use of Firmagon (degarelix) for advanced prostate cancer

Written by | 2 Oct 2015

Firmagon (Degarelix) is a competitive, reversible GnRH receptor blocker, for patients with advanced hormone-dependent prostate cancer.  Where Injection technique is critical;  Nora Sullivan, a specialist nurse at Hibernian… read more.

Green light for new medicines

Written by | 31 Aug 2015

by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.

New approach to prostate cancer treatment increases survival for some patients

Written by | 28 Aug 2015

by Bruce Sylvester: Among patients with metastatic hormone-sensitive prostate cancer, chemotherapy with docetaxel at the start of androgen deprivation therapy (ADT) has resulted in an increased survival of… read more.

Pioglitazone treatment not linked to bladder cancer

Written by | 27 Aug 2015

by Bruce Sylvester: Treatment of diabetes with pioglitazone does not appear to be related to an increased risk of bladder cancer, researchers from an analysis including nearly 200,000… read more.

Oral contraceptive use lowers endometrial cancer risk

Written by | 26 Aug 2015

by Bruce Sylvester: Oral contraceptive use appears to provide long-term protection against endometrial cancer, researchers reported on August 4, 2015 in The Lancet Oncology.

ICML 2015 Poster Session: Hodgkin lymphoma: PET-CT or bone marrow biopsy?

Written by | 28 Jul 2015

Zeinab Ali Abou Yehia et al, Houston, TX, USA / by Maria Dalby.  PET-CT scans appear to be more sensitive than bone marrow biopsies for detecting bone marrow… read more.

ICML 2015 Report: Thirty years of progress in cutaneous lymphoma research

Written by | 28 Jul 2015

John Ultmann Memorial Lecture / by Maria Dalby.  Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.

ICML 2015 Report: Update on the revision of the WHO lymphoma classification

Written by | 28 Jul 2015

Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby.  Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.

Spectrum of sun skin damage documented

Written by | 15 Jul 2015

Scientists at Newcastle University have documented for the first time the DNA damage which can occur to skin across the full range of ultraviolet radiation from the sun… read more.

Rociletinib could become a “game changer” in treating EGFR-mutation driven lung tumors which have become treatment resistant

Written by | 6 Jul 2015

by Bruce Sylvester: Rociletinib, an investigative therapy for treatment resistant EGFR-mutation driven lung tumors, shows activity against the most common resistance mutation, and it significantly improves clinical  outcomes.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.